These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6835477)

  • 1. Dopamine creates a physical barrier to inhibit prolactin release in mammotrophs of estradiol-primed male rats.
    Reifel CW; Saunders SL; Shin SH
    Neuroendocrinology; 1983; 36(3):242-8. PubMed ID: 6835477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-induced physical barrier to inhibit prolactin release in mammotrophs disappears during resumption of prolactin secretion.
    Reifel CW; Shin SH; Saunders SL
    Neuroendocrinology; 1985 May; 40(5):438-43. PubMed ID: 4010889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive ultrastructural changes in rat mammotrophs following administration of the dopamine agonist ergocristine-reflecting inhibition of prolactin release.
    Reifel CW; Shin SH; Leather RA
    Cell Tissue Res; 1983; 232(2):249-56. PubMed ID: 6688378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural changes rapidly induced by somatostatin may inhibit prolactin release in estrogen-primed rat adenohypophysis.
    Saunders SL; Reifel CW; Shin SH
    Cell Tissue Res; 1983; 232(1):21-34. PubMed ID: 6136330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine acts immediately to inhibit prolactin release and induce cellular changes in estradiol-primed male rats.
    Saunders SL; Shin SH; Reifel CW
    Neuroendocrinology; 1984 Mar; 38(3):182-8. PubMed ID: 6325979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural changes in rat mammotropes following incubation with dopamine.
    Joneja M; Reifel CW; Murphy ML; Shin SH
    Experientia; 1993 Oct; 49(10):836-9. PubMed ID: 8224096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between suckling-induced changes in the ultrastructure of mammotrophs and prolactin release.
    Chang NG; Nikitovitch-Winer MN
    Cell Tissue Res; 1976 Feb; 166(3):399-406. PubMed ID: 1253239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin inhibits prolactin secretion in the estradiol primed male rat.
    Cooper GR; Shin SH
    Can J Physiol Pharmacol; 1981 Oct; 59(10):1082-8. PubMed ID: 6119146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-hydroxyoestradiol inhibits prolactin release from the superfused rat pituitary gland.
    Linton EA; White N; Lira de Tineo O; Jeffcoate SL
    J Endocrinol; 1981 Sep; 90(3):315-22. PubMed ID: 7276793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal dynamics of pituitary prolactin depletion and release in three strains of rats.
    Phelps SJ; Moy JA; Lawson DM
    Life Sci; 1991; 49(26):1965-72. PubMed ID: 1749308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the prolactin rebound after dopamine withdrawal in rat pituitary cells.
    Chen C; Zhang J; Israel JM; Clarke IJ; Vincent JD
    Am J Physiol; 1993 Jul; 265(1 Pt 1):E145-52. PubMed ID: 8393290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the kinetics of dopamine-regulated prolactin secretion.
    Kramer IM; Hopkins CR
    Mol Cell Endocrinol; 1982 Oct; 28(2):191-8. PubMed ID: 7128924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does dopamine inhibit or stimulate prolactin release in vitro? The effects of dopamine concentration and duration of in vivo estradiol treatment.
    Parker P; Lawson D
    Proc Soc Exp Biol Med; 1993 Apr; 202(4):451-6. PubMed ID: 8456110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Hydroxyoestradiol acutely inhibits prolactin secretion from the superfused pituitary glands of normal female rats: evidence for a cyclical effect.
    Banks PK; Inkster SE; White N; Jeffcoate SL
    J Endocrinol; 1986 Nov; 111(2):199-204. PubMed ID: 3794579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S; Boyadjieva N; Sarkar DK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the mammotroph Golgi complex by the dopamine agonist 2 Br-alpha-ergocryptine (CB-154) in ovariectomized estrogen primed rats.
    Poole MC; Easley CS; Hodson CA
    Anat Rec; 1991 Nov; 231(3):339-46. PubMed ID: 1763815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ovarian steroid hormones on dopamine-controlled prolactin secretory responses in vitro.
    Close FT; Freeman ME
    Neuroendocrinology; 1997 Jun; 65(6):430-5. PubMed ID: 9208405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
    Kimura N; Hayafuji C; Konagaya H; Takahashi K
    Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin crinophagy is induced in the estrogen-stimulated male rat pituitary.
    Kuriakose NR; Reifel CW; Bendayan M; Elce JS; Shin SH
    Histochemistry; 1989; 92(6):499-503. PubMed ID: 2807996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogens on the ultrastructural characteristics of female rat prolactin cells as evaluated by in situ hybridization in combination with immunogold staining technique.
    Tong Y; Zhao H; Labrie F; Pelletier G
    Neuroendocrinology; 1990 Oct; 52(4):309-15. PubMed ID: 2124656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.